These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21236307)

  • 1. Is there any association between HCV multiplication and iron induced liver injury in chronic hepatitis C?
    Sikorska K; Stalke P; Bielawski KP
    J Hepatol; 2011 Jul; 55(1):235-6: author reply 236-7. PubMed ID: 21236307
    [No Abstract]   [Full Text] [Related]  

  • 2. Iron inhibits replication of infectious hepatitis C virus in permissive Huh7.5.1 cells.
    Fillebeen C; Pantopoulos K
    J Hepatol; 2010 Dec; 53(6):995-9. PubMed ID: 20813419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte iron accumulation: a new string to ribavirin's antiviral bow?
    Ryan JD; Crowe J
    J Hepatol; 2011 Jul; 55(1):237-8; author reply 238. PubMed ID: 21349299
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes.
    Watashi K; Hijikata M; Hosaka M; Yamaji M; Shimotohno K
    Hepatology; 2003 Nov; 38(5):1282-8. PubMed ID: 14578868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
    Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K
    J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The heme oxygenase 1 product biliverdin interferes with hepatitis C virus replication by increasing antiviral interferon response.
    Lehmann E; El-Tantawy WH; Ocker M; Bartenschlager R; Lohmann V; Hashemolhosseini S; Tiegs G; Sass G
    Hepatology; 2010 Feb; 51(2):398-404. PubMed ID: 20044809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyurea as an inhibitor of hepatitis C virus RNA replication.
    Nozaki A; Morimoto M; Kondo M; Oshima T; Numata K; Fujisawa S; Kaneko T; Miyajima E; Morita S; Mori K; Ikeda M; Kato N; Tanaka K
    Arch Virol; 2010 Apr; 155(4):601-5. PubMed ID: 20204428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
    Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
    Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyurea suppresses HCV replication in humans: a Phase I trial of oral hydroxyurea in chronic hepatitis C patients.
    Nozaki A; Numata K; Morimoto M; Kondo M; Sugimori K; Morita S; Miyajima E; Ikeda M; Kato N; Maeda S; Tanaka K
    Antivir Ther; 2010; 15(8):1179-83. PubMed ID: 21149925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unveiling extrahepatic consequences of chronic hepatitis C--the REVEAL-HCV study.
    Barreiro P
    AIDS Rev; 2012; 14(4):290-1. PubMed ID: 23390674
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis C, innate immunity and alcohol: friends or foes?
    Osna NA; Ganesan M; Kharbanda KK
    Biomolecules; 2015 Feb; 5(1):76-94. PubMed ID: 25664450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C.
    Ferraro D; Bonura C; Giglio M; Di Stefano R; Almasio PL; Di Marco V; Craxì A; Cacciola I; Squadrito G; Raimondo G
    J Biol Regul Homeost Agents; 2003; 17(2):172-5. PubMed ID: 14518718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of hepatitis C virus replication by cyclin-dependent kinase inhibitors.
    Munakata T; Inada M; Tokunaga Y; Wakita T; Kohara M; Nomoto A
    Antiviral Res; 2014 Aug; 108():79-87. PubMed ID: 24893207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The flavonoid apigenin inhibits hepatitis C virus replication by decreasing mature microRNA122 levels.
    Shibata C; Ohno M; Otsuka M; Kishikawa T; Goto K; Muroyama R; Kato N; Yoshikawa T; Takata A; Koike K
    Virology; 2014 Aug; 462-463():42-8. PubMed ID: 25092460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular mechanisms of hepatitis C virus (HCV) replication - implications for the development of antiviral drugs].
    Bühler S; Bartenschlager R
    Z Gastroenterol; 2011 Jul; 49(7):836-44. PubMed ID: 21766263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galactosylated Lipidoid Nanoparticles for Delivery of Small Interfering RNA to Inhibit Hepatitis C Viral Replication In Vivo.
    Park HJ; Jeon EJ; Lee JS; Hong SH; Cho AN; Lee J; Moon JS; Jung KE; Oh JW; Lee H; Cho SW
    Adv Healthc Mater; 2016 Nov; 5(22):2931-2941. PubMed ID: 27774775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus.
    Choi J; Ou JH
    Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G847-51. PubMed ID: 16603728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of steroids on hepatitis C virus replication in vivo and in vitro.
    Henry SD; Metselaar HJ; Van Dijck J; Tilanus HW; Van Der Laan LJ
    Ann N Y Acad Sci; 2007 Sep; 1110():439-47. PubMed ID: 17911459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of intracellular hepatitis C virus replication by nelfinavir and synergistic effect with interferon-alpha.
    Toma S; Yamashiro T; Arakaki S; Shiroma J; Maeshiro T; Hibiya K; Sakamoto N; Kinjo F; Tateyama M; Fujita J
    J Viral Hepat; 2009 Jul; 16(7):506-12. PubMed ID: 19302339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins and HCV: a complex issue.
    Lonardo A; Loria P; Bertolotti M; Carulli N
    Hepatology; 2007 Jan; 45(1):257. PubMed ID: 17187410
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.